What is the main therapeutic use of drugs that act on the IIb/IIIa receptors?

Drugs that act on the IIb/IIIa receptors are primarily used as anti-platelet therapy, particularly in the management of acute coronary syndromes. These receptors, found on the surface of platelets, play a crucial role in platelet aggregation and the formation of blood clots. By inhibiting these receptors, drugs prevent platelets from sticking together and forming clots, which is essential during acute events such as myocardial infarction or unstable angina.

This therapeutic action significantly reduces the risk of further complications associated with these conditions, aiding in better patient outcomes. In contrast, the other choices involve conditions or mechanisms where IIb/IIIa receptor antagonists have no role; for instance, treating hypertension typically involves other classes of medication, anxiety disorders are managed with anxiolytics, and seizures are treated with anticonvulsants, none of which target the platelet aggregation pathway directly.